Aleafia Inc & Emblem Corp CEOs, MJardin Group - Midas Letter RAW 127
2,437 views · Published 19 December 2018 · 1:29:07 · Indexed 2 October 2026
Channel: Midas Letter · 2018 · News & Politics
Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. James West and Ed Milewski provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business. 0:00 - Macroeconomics and Cannabis Analysis with James & Ed -Big news: Aleafia Health (CVE:ALEF) and Emblem Corp (CVE:EMC) merged -Today: CEOs from both Aleafia and Emblem, MJardin Group CEO, Benjamin A. Smith 2:24 - Midas Letter News -Aleafia Health (CVE:ALEF) purchasing Emblem Corp (CVE:EMC); valued at $173M; when completed, Emblem shareholders will own 41% of Aleafia -Wayland Group (CNSX:WAYL) exploring spinout and alternatives for European assets -CannTrust (TSE:TRST) Phase 2 expansion on course; also built 35,000 square foot facility -Agraflora (CNSX:AGRA) has issues 12M shares to shareholders of AAA Heidleberg -Canopy Rivers Inc (CVE:RIV) shares have receive full eligibility in US identifier CNPOF -High Hampton (CNSX:HC) approval for new 2500 square foot production facility in Coachella 6:34 - Macroeconomics and Cannabis Analysis with James & Ed -consolidation going on -Aleafia and Emblem merger; makes so much sense; Emblem has the capacity, Aleafia has the patients and clinics -Fed raised rates -Wayland Group press release: initiated process to explore spinning out Euro assets into one company; Canadian assets into another; shareholders get share in both -Wayland chart -S&P: tanked, but rallied a bit 16:52 - MJardin Group Inc (CNSX:MJAR) (OTCMKTS:MJARF) is an experienced cannabis platform, operating in the legal market since 2009. Executive Chairman Rishi Gautam explains MJardin is in a transition phase, evolving from an agency business model to a principal model as it takes on assets to own and operate. 25:25 - Macroeconomics and Cannabis Analysis with James & Ed -MJardin chart: 6 green candles, 19 red candles out of 25 days of trading -got it all -62M shares outstanding -Ex. Tilray had right kind of investors -Q1 investing in cannabis put downward pressure on space -Q: Look up ACRG.U? A: incredibly skeptical of Acreage; stocks giveaways -Acreage chart (very similar to MJardin) 7 green and 18 red; more volatile; getting close to a buy from a technical perspective 35:20 - Aleafia Health Inc (CVE:ALEF) (OTCMKTS:ALEAF) (FRA:ARAH) grabbed headlines by announcing the acquisition Emblem Corp (CVE:EMC) (OTCMKTS:EMMBF) (FRA:E0M). The all-share transaction is valued at approximately $173 million and will significantly alter the medical cannabis landscape in Canada. CEOs Geoff Benic (CVE:ALEF) and Nick Dean (CVE:EMC) visit the Midas Letter set to explain the merger. 43:12 - Macroeconomics and Cannabis Analysis with James and Ed -Emblem warrants; have to be transferred, can't just be cancelled; become warrants of Aleafia -why should shareholders be happy? Combined entity has much better chance of generating profit in the short term; creates the vertical integration you want -understand why shareholders would be upset because of earlier price highs -Q: Aleafia patients or patient encounters? A: weren't an LP, now an LP with a client base Question: stay long or liquidate: ACB, WEED, APHA? A: Sell the Aphria, take the tax loss; take the gain on Canopy; basically any stocks you bought post Sept, sell to lock in the tax loss Q: can't claim tax loss from TFSA A: wait for greener profits -James: cannabis not a bubble, but a pair of lungs (inhale and exhale); Ed:....it was a bubble 1:03:34 - Midas Big Moments 2018 1:10:07 - Macroeconomics and Cannabis Analysis with James & Ed -10 year rate dropped dramatically 1:15:20 - Midas Letter Senior Writer Benjamin A. Smith shares his impressions of the Aleafia-Emblem merger and why some shareholders might be upset. Smith notes that the current realities dictate that some of these juniors have to merge and that many of the highs cannabis juniors saw earlier in 2018 won’t return anytime soon. ************************ Check out our website: https://midasletter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our 2nd YouTube Channel - Midas Letter Clips: https://bit.ly/2rtQzgy SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************ #WeedStocks #TechnicalAnalysis #MidasLetter
More from this channel
-
6:42
GreenBank CEO Danny Wettreich on Investing in Ubique and Blockchain Evolution
-
7:50
Paycase Financial CEO Joseph Weinberg on Bitcoin Technology for Overseas Transactions
-
6:13
NeutriSci is into Energy Tablets, THC, and Genie Bouchard!
-
7:45
Current Water Technologies is Using Their Patents to Clean Public Water Around the World
-
9:36
Aereus Technologies Prevents Spread of Infections with Copper Thermal Coating, Microbial Tech
-
6:12
Investor Derek Sinclair on Cryptocurrency Opportunities
-
7:16
LiveWell Foods (CVE:LVWL) CEO Seann Poli on Cannabis Bioceuticals
-
7:16
NuRan Wireless Inc (CNSX:NUR) VP of Marketing Francis Letourneau on Cellular Transmission Tech